CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Damora Therapeutics Begins Trial of DMR-001 in ET, Myelofibrosis

Trial StartDMR-001Positive
AI Analysis

Summary

Damora Therapeutics has initiated a clinical trial of DMR-001 for the treatment of essential thrombocythemia and myelofibrosis.

Clinical Trial Data

Importance:4/10
Sentiment:
0.50
clinical trialdrug developmenthematology
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 2:42 PM

Read Original